Obesity-related cancer mortality in the US (1999–2020): A CDC WONDER analysis.
Abstract
e23052 Background: Obesity is a major public health issue and a key risk factor for various cancers. This study examines U.S. mortality trends (1999–2020), focusing on demographic, geographic, and urbanization disparities. Methods: CDC WONDER mortality data (ages 25+) from 1999–2020 were analyzed. Age-adjusted mortality rates (AAMRs) per million were calculated by gender, race/ethnicity, age, urbanization, and region. Joinpoint regression assessed trends, yielding average annual percentage change (AAPC) with 95% confidence intervals (CIs) and p-values. Results: Obesity-related cancers caused 33,572 deaths. AAMRs rose from 3.73/million (95% CI 3.45–4.01) in 1999 to 13.52/million (95% CI 13.08–13.97) in 2020 (AAPC: 5.92%; 95% CI 5.23–6.44; p < 0.000001). Females had higher AAMRs (7.22/million; 95% CI 7.12–7.32) than males (6.59/million; 95% CI 6.48–6.70). AAPC was 5.37% for females (95% CI 4.58–5.98; p < 0.000001) and 6.75% for males (95% CI 6.23–7.24; p < 0.000001). Blacks had the highest AAMRs (9.2/million; 95% CI 8.92–9.47), followed by American Indians (9.04/million; 95% CI 7.90–10.18) and Whites (7.13/million; 95% CI 7.04–7.22). Hispanics showed the steepest AAPC (6.31%; 95% CI 3.78–9.29; p < 0.000001). Mortality was highest in adults 65+ (AAMR: 20.82/million; 95% CI 20.52–21.11) with an AAPC of 6.26% (95% CI 5.39–6.90; p < 0.000001). The Midwest had the highest AAMR (7.96/million; 95% CI 7.79–8.13), while the Northeast had the lowest (5.7/million; 95% CI 5.54–5.85). Rural areas had higher AAMRs (9.45/million; 95% CI 9.24–9.66) than urban areas (6.4/million; 95% CI 6.32–6.48), with rural rates rising more sharply (AAPC: 6.98%; 95% CI 5.97–8.75; p < 0.000001). Most deaths occurred in inpatient medical facilities (13,373), followed by homes (10,251). Conclusions: Obesity-related cancer mortality has risen sharply (1999–2020), with disparities by gender, race, geography, and urbanization. Targeted public health efforts are needed for high-risk groups, particularly older adults, rural residents, and minorities, to curb mortality rates. Cohort Age Adjusted Mortality Rate Average Annual Percentage Change 95% Confidence Intervel P-Value 1999-2020 Overall 6.91 5.9154* 5.2327-6.4383 < 0.000001 Female 7.22 5.3651* 4.5786-5.9763 < 0.000001 Male 6.59 6.7506* 6.2337-7.2375 < 0.000001 African American 9.2 5.3656* 4.7002-6.0455 < 0.000001 White 7.13 6.1847* 5.5699-6.6384 < 0.000001 Hispanic 7.13 6.3087* 3.784-9.2911 < 0.000001 Northeast 5.7 5.5577* 4.2074-6.4733 < 0.000001 Midwest 7.96 6.0083* 5.2882-6.6144 < 0.000001 South 6.45 6.5877* 5.8531-7.2197 < 0.000001 West 7.7 5.4055* 4.7-6.4746 < 0.000001 Less than 65 3.54 5.4362* 4.7101-5.9887 < 0.000001 above 65 20.82 6.2611* 5.3948-6.9027 < 0.000001 Urban 6.4 6.0294* 5.3265-6.6022 < 0.000001 Rural 9.45 6.9779* 5.9664-8.7491 < 0.000001
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (14)
Kainat Aman
Batterjaee Medical College, Jeddah, Saudi Arabia
Abdullah Zia
6Ameer-ud-din Medical College, Lahore, Pakistan
Aman Ullah
Faizan Ahmed
Najam Gohar
Ameer-ud-Din Medical College, Sialkot, Pakistan
Izzah Nayyab
Allama Iqbal Medical College, Lahore, Pakistan
Tehmasp Mirza
Shalamar Medical and Dental College, Lahore, Pakistan
Mohammad Hossain
Yusra Junaid
Dow Medical College, Karachi, Pakistan
Sherif Eltawansy
Mohamed Bakr
Jersey Shore, New Jersey, NJ
Hira Zahid
Dow Medical College, Karachi, Pakistan
Adnan Bhat
University of Florida, Gainesville, FL
Abdul Waheed
Department of Biochemistry and Molecular Biology, School of Medicine, St. Louis University